Page last updated: 2024-09-05

deflazacort and Bone Fractures

deflazacort has been researched along with Bone Fractures in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmed, SF; Bushby, K; Guglieri, M; Horrocks, I; Joseph, S; Straub, V; Wang, C; Wong, SC1
Jefferies, JL; McMahon, MA; Rutter, MM; Rybalsky, I; Sawnani, H; Shellenbarger, KC; Tian, C; Wong, BL1
Alman, BA; Biggar, WD; Mayo, AL; McAdam, LC1
Biggar, WD; Craven, BC; Mayo, AL; McAdam, LC1
Alman, B; Biggar, WD; Comi, LI; Harris, VA; Nigro, G; Palladino, A; Passamano, L; Politano, L; Vajsar, J1
Cuartero Lobera, J; Longás Valién, J; Pérez Barrero, P; Ruiz Garcés, T1
Bérubé, D; Brousseau, Y; D'Arcy, S; Dubé, J; Filiatrault, M; Fournier, A; Houde, S; Lapierre, G; Vanasse, M1

Trials

2 trial(s) available for deflazacort and Bone Fractures

ArticleYear
Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols.
    Neuromuscular disorders : NMD, 2004, Volume: 14, Issue:8-9

    Topics: Adolescent; Body Height; Body Weight; Calcium; Case-Control Studies; Cataract; Child; Clinical Protocols; Dietary Supplements; Drug Administration Schedule; Follow-Up Studies; Fractures, Bone; Humans; Immunosuppressive Agents; Male; Motor Activity; Muscular Dystrophy, Duchenne; Pregnenediones; Psychomotor Performance; Scoliosis; Treatment Outcome; Vitamin D

2004
Deflazacort use in Duchenne muscular dystrophy: an 8-year follow-up.
    Pediatric neurology, 2008, Volume: 38, Issue:3

    Topics: Adolescent; Adult; Anti-Inflammatory Agents; Body Height; Body Weight; Bone Density; Cataract; Fractures, Bone; Humans; Longitudinal Studies; Male; Muscular Dystrophy, Duchenne; Pregnenediones; Scoliosis; Treatment Outcome

2008

Other Studies

5 other study(ies) available for deflazacort and Bone Fractures

ArticleYear
Fractures and Linear Growth in a Nationwide Cohort of Boys With Duchenne Muscular Dystrophy With and Without Glucocorticoid Treatment: Results From the UK NorthStar Database.
    JAMA neurology, 2019, 06-01, Volume: 76, Issue:6

    Topics: Adolescent; Back Pain; Body Height; Bone Density Conservation Agents; Case-Control Studies; Child; Cohort Studies; Diphosphonates; Fractures, Bone; Glucocorticoids; Growth Disorders; Humans; Incidence; Male; Muscular Dystrophy, Duchenne; Osteoporosis; Osteoporotic Fractures; Pregnenediones; Proportional Hazards Models; Retrospective Studies; Risk Factors; Spinal Fractures; United Kingdom

2019
Long-Term Outcome of Interdisciplinary Management of Patients with Duchenne Muscular Dystrophy Receiving Daily Glucocorticoid Treatment.
    The Journal of pediatrics, 2017, Volume: 182

    Topics: Adolescent; Age Factors; Child; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Exercise Therapy; Follow-Up Studies; Fractures, Bone; Glucocorticoids; Humans; Insulin Resistance; Long-Term Care; Male; Muscular Dystrophy, Duchenne; Osteoporosis; Patient Care Team; Prednisone; Pregnenediones; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome; Weight Gain

2017
The Canadian experience with long-term deflazacort treatment in Duchenne muscular dystrophy.
    Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology, 2012, Volume: 31, Issue:1

    Topics: Adolescent; Adrenal Cortex Hormones; Body Height; Bone Density; Canada; Cataract; Child; Fractures, Bone; Humans; Immunosuppressive Agents; Male; Muscle Strength; Muscular Dystrophy, Duchenne; Pregnenediones; Spinal Injuries; Spine; Walking; Weight Gain

2012
Bone health in boys with Duchenne Muscular Dystrophy on long-term daily deflazacort therapy.
    Neuromuscular disorders : NMD, 2012, Volume: 22, Issue:12

    Topics: Adolescent; Anti-Inflammatory Agents; Body Height; Bone and Bones; Bone Density; Child; Fractures, Bone; Humans; Male; Muscular Dystrophy, Duchenne; Pregnenediones; Quality of Life; Risk Factors; Time Factors

2012
[Anesthetic management in immunoglobulin A deficiency syndrome associated with juvenile chronic arthritis].
    Revista espanola de anestesiologia y reanimacion, 2006, Volume: 53, Issue:9

    Topics: Anesthesia, Inhalation; Arthritis, Juvenile; Child; Disease Susceptibility; Female; Fractures, Bone; Humans; IgA Deficiency; Immunosuppressive Agents; Intellectual Disability; Intraoperative Complications; Intubation, Intratracheal; Nasal Cavity; Osteoporosis; Preanesthetic Medication; Pregnenediones; Preoperative Care; Surgery, Oral; Turbinates

2006